James Riley

20PUBLICATIONS
128CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Micro- and nanosystemsHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 10, 2026
HIV-specific and resistant CAR T cells promote control of HIV replication in people with HIV.

|May 05, 2026
Rab5 improves CAR T cell efficacy via reducing fratricide and maintaining surface CAR levels.

|Feb 24, 2026
Antigen-boosted CD4CAR T cells fail to expand or control viremia in multiple nonhuman primate models of HIV.

Lucy Maynard, Carly E Starke, Nikhita Hegde Poole

|Feb 12, 2026
Cell-derived Nanoparticles Provide a Robust Platform to Manufacture Therapeutic T cells.

Mosha Z Deng, Tanishk Sinha, Meizan Lai

|Feb 06, 2026
The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target.

Zhiwei Ang, Annette Castro, Luca Paruzzo

|Oct 21, 2025
CCR5-targeted allogeneic gamma-delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapy.

Ángel Ramírez-Fernández, Alexander J Dimitri, Fang Chen

Pageof 4

Frequent Collaborators

5 joint publications

Carl June

4 joint publications

Julie K Jadlowsky

4 joint publications

Donald Siegel

4 joint publications

Joseph Fraietta